TER Form 4: Director Peter Herweck Acquires 206 DSUs, Total 15,205 Shares
Rhea-AI Filing Summary
Peter Herweck, a director of Teradyne, Inc. (TER), deferred his quarterly cash compensation into 206 deferred stock units (DSUs) on 09/25/2025. The filing shows the 206 DSUs were issued at a $0 price per unit (per reporting convention) and that after this transaction the reporting person beneficially owned 15,205 shares of Teradyne common stock. The DSUs are calculated based on the closing price on the issuance date and will be settled one-for-one in common stock generally within ninety days after the director ceases to serve as a non-employee director. The Form 4 was signed by an attorney-in-fact on 09/29/2025.
Positive
- Director increased equity alignment by deferring cash compensation into 206 DSUs
- Total beneficial ownership disclosed at 15,205 shares provides transparency for investors
Negative
- None.
Insights
TL;DR: Routine director deferral into DSUs indicates alignment with shareholder interests and standard non-employee director compensation practice.
This Form 4 reports a director-level compensation deferral rather than a market purchase or sale. Converting cash retainer into 206 DSUs is a common governance practice to align non-employee directors with long-term equity ownership. The filing discloses the mechanics: DSUs are priced using the closing stock price at issuance and convert one-for-one to common stock within ninety days after the director leaves the board. There is no indication of option exercises, sales, or derivative transactions in this filing, and the overall beneficial ownership reported is 15,205 shares.
TL;DR: Transaction is immaterial to company capitalization but notable for tracking director ownership levels.
The reported acquisition of 206 DSUs on 09/25/2025 increases the reporting person's stake to 15,205 shares. Because this is a compensation deferral settled in DSUs, it does not reflect open-market trading and carries no immediate cash transfer related to share purchase. The Form 4 contains no derivatives, dispositions, or other transactions that would materially affect float or signal large insider liquidity events. Impact on valuation or market supply is therefore negligible based on the disclosed data.